Mike McCormick is a seasoned executive with over 25 years of experience in leading medical device companies and serving as a board member for several private and publicly traded life science companies.
From 2010 to 2022 Mike served as CEO of Osprey Medical, an Interventional Cardiology commercial stage medical device company, publicly traded, and focused on technologies to reduce Contrast Induced Acute Kidney Injury.
From 2003 to 2008, he was CEO of Anulex Technologies Inc., a private company focused on developing proprietary technologies to support the healing of spinal soft tissues that was successfully sold to Boston Scientific.
Prior to this Mike was President of Centerpulse Spine-Tech a publicly traded full line supplier of innovative spinal technologies. Mike was involved in the successful sale of Centerpulse Spine-Tech to Zimmer in the fall of 2003.
Early in his career Mike worked at Boston Scientific Scimed and Baxter Health Care where he served in a variety of sales and sales management roles. Mike received his Bachelor of Business Administration, Business Management from The University of Texas at Austin.
Mike is a member of the Board of Directors of Osprey Medical, Inc., and Formae, Inc. Previous Board experience includes Chairman of OrthoCor Medical which was sold in 2019, Director Cardio Renal Society of America and Board of Anulex Technologies, Inc.